2 1 Shi Ji Jing Ji Bao Dao·2026-01-18 10:06Market Performance - The A-share market showed mixed performance from January 12 to January 16, with the Shanghai Composite Index closing at 4101.91 points, down 0.45% for the week, while the Shenzhen Component Index rose 1.14% to 14281.08 points, and the ChiNext Index increased by 1.00% to 3361.02 points [1] - Over 54% of stocks experienced gains during the week, with 156 stocks rising over 15% and 50 stocks declining more than 15% [1] Sector Performance - Sectors that saw gains included Computer, Electronics, Non-ferrous Metals, Media, and Machinery Equipment, while sectors such as Defense, Real Estate, Agriculture, Coal, and Banking experienced declines [1] Top Gainers - The top-performing stock was Bofei Electric (001255.SZ) with a weekly increase of 61.06%, followed by Tongyuan Environment (688679.SH) at 58.66%, and several others exceeding 45% [3] - Bofei Electric operates in the chemical raw materials industry, focusing on the research, production, and sales of electrical insulation materials [4] Investment and Financials - Bofei Electric's stock closed at 55.21 yuan per share, marking five consecutive days of trading limit increases [5] - The State Grid Corporation announced a planned investment of 4 trillion yuan during the 14th Five-Year Plan, a 40% increase from the previous plan [5] - Bofei Electric announced an investment of 23.38 million yuan in Haining Qiyuan Real Estate Co., Ltd. to enhance local business connections [5] Top Losers - The worst-performing stock was Sunflower (300111.SZ) with a decline of 37.48%, followed by *ST Lifan (300344.SZ) and *ST Changyao (300391.SZ), both dropping over 26% [8] - Sunflower focuses on the pharmaceutical sector, primarily developing and selling drugs for infections, cardiovascular issues, and digestive systems [8] Regulatory Actions - The Zhejiang Securities Regulatory Bureau has initiated an investigation into Sunflower for misleading statements in its restructuring proposal [8][9] - The proposal involved acquiring 100% of Xipu Materials Technology Co., Ltd. and 40% of Beid Pharmaceutical Co., Ltd., but raised concerns regarding the actual production capacity of the target companies [10][12]